Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) Net Tangible Assets

As of the most recent data (December 2022), EUCRU shows a net tangible assets of $8.5M. That compares with $-5.5M in the prior-year period — up 255.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EUCRU's net tangible assets is now $8.5M (was $-5.5M) — a 255.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) is outperforming or lagging.

Tracking EUCRU's net tangible assets over time shows whether Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $8.5M That compares with $-5.5M in the prior-year period — up 255.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $8.5M) with ownership activity and broader fundamentals.